Julien Poissy

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites et al. · The Lancet Infectious Diseases · 2021 · 338 citations · Full text

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot et al. · The Lancet Respiratory Medicine · 2021 · 293 citations · Full text

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

Christiana Kartsonaki, J. Kenneth Baillie, Noelia García Barrio et al. · International Journal of Epidemiology · 2023 · 68 citations · Full text

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Marius Trøseid, José Ramón Arribas, Lambert Assoumou et al. · Critical Care · 2023 · 46 citations · Full text

Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial

Florence Ader, Nathan Peiffer‐Smadja, Julien Poissy et al. · 2021 · 15 citations · Full text

Hydroxychloroquine Efficacy, Pharmacotherapy, Covid-19 Epidemiology +16